Results 101 to 110 of about 333 (136)

Unexpected Low Rate of Amyloid-β Pathology in Multiple Sclerosis Patients. [PDF]

open access: yesAnn Neurol
Brier MR   +18 more
europepmc   +1 more source

Single-cell landscape of innate and acquired drug resistance in acute myeloid leukemia. [PDF]

open access: yesNat Commun
Wegmann R   +41 more
europepmc   +1 more source

Proteotyping: Proteomic characterization, classification and identification of microorganisms – A prospectus

Systematic and Applied Microbiology, 2015
Modern microbial systematics requires a range of methodologies for the comprehensive characterization, classification and identification of microorganisms. While whole-genome sequences provide the ultimate reference for defining microbial phylogeny and taxonomy, selected biomarker-based strategies continue to provide the means for the bulk of microbial
Stefan Hulth   +2 more
exaly   +4 more sources

Label-Free Multiplex Proteotyping of Microbial Isolates

Analytical Chemistry, 2023
To meet clinical diagnostic needs and for general microbiological screening, it is essential to be able to accurately and rapidly identify any microorganisms from complex microbiota. To gain insight into the individual components of microbiota, culturomics has been proposed as a means to systematically test hundreds of possible cultivation conditions ...
Chabas, Madisson   +3 more
openaire   +4 more sources

Proteotyping pluripotency with mass spectrometry

Expert Review of Proteomics, 2019
Pluripotency emerges transiently during embryogenesis in two main forms with different developmental potential, termed naïve and primed states. Importantly, these pluripotent states can be recapitulated in vitro under specific culture conditions, representing a unique model to study the regulatory principles of development and cellular plasticity ...
Cristina, Sayago   +2 more
openaire   +2 more sources

Computational prediction of proteotypic peptides

Expert Review of Proteomics, 2007
Evaluation of: Mallick P, Schirle M, Chen SS et al. Computational prediction of proteotypic peptides for quantitative proteomics. Nat. Biotechnol. 25(1), 125–131 (2007).Mass spectrometry, the driving analytical force behind proteomics, is primarily used to identify and quantify as many proteins in a complex biological mixture as possible.
Josip, Blonder, Timothy D, Veenstra
openaire   +2 more sources

Scoring proteomes with proteotypic peptide probes

Nature Reviews Molecular Cell Biology, 2005
Technologies for genome-wide analyses typically undergo a transition from a discovery phase to a scoring phase. In the discovery phase, the genomic universe is explored and all pertinent data are noted. In the scoring phase, relevant entities are screened to reveal groups of genes that are associated with specific biological processes or conditions. In
Bernhard, Kuster   +3 more
openaire   +2 more sources

Proteotypic Peptides and Their Applications

2016
Recent advances in mass spectrometry based proteomic techniques and publicly available large proteomic repositories are being exploited to characterize the proteome of multiple organisms. While humongous amount of proteomic data is being acquired and analyzed, many biological questions still remain unanswered.
Shivakumar, Keerthikumar   +1 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy